Pacira Pharmaceuticals (PCRX) PT Raised to $94 at Barclays
Tweet
Share
E-mailGet Alerts PCRX Hot Sheet
Price: $23.00 --0%
Rating Summary:
12 Buy, 15 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 19
Rating Summary:
12 Buy, 15 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 19
Join SI Premium – FREE
Barclays analyst Balaji Prasad raised the price target on Pacira Pharmaceuticals (NASDAQ: PCRX) to $94.00 (from $79.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Truist Securities Reinstates Pacira Pharmaceuticals (PCRX) at Buy
- Gemini Space Station (GEMI) PT Lowered to $6 at Rosenblatt
- Yesway Inc (YSWY) PT Raised to $32 at Guggenheim
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
